|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.190 USD | -9.38% |
|
-7.80% | -37.82% |
| 07-06 | Alvotech Faces 'Soft' Q2 but Well Positioned to Benefit From Upcoming Biosimilar Opportunity, UBS Says | MT |
| 07-01 | Alvotech announced that it has received $175 million in funding | CI |
Company Valuation: Alvotech
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 308.8 | 2,486 | 3,048 | 3,991 | 1,606 | 1,092 | - | - |
| Change | - | 705.34% | 22.59% | 30.92% | -59.76% | -31.99% | - | - |
| Enterprise Value (EV) 1 | 308.8 | 3,165 | 3,959 | 5,330 | 2,883 | 2,140 | 2,173 | 2,050 |
| Change | - | 925.01% | 25.11% | 34.63% | -45.92% | -25.75% | 1.52% | -5.65% |
| P/E | -0.8x | -3.85x | -4.72x | -15.2x | 9.5x | 8.31x | 7.09x | 4.81x |
| PBR | - | -4.41x | -2.8x | -8.59x | -5.22x | -3.12x | -3.62x | -8.05x |
| PEG | - | 0x | 0.72x | 0.2x | -0x | -0.3x | 0.4x | 0.1x |
| Capitalization / Revenue | 8.4x | 29.9x | 32.6x | 8.11x | 2.73x | 1.65x | 1.37x | 1.11x |
| EV / Revenue | 8.4x | 38.1x | 42.4x | 10.8x | 4.9x | 3.24x | 2.72x | 2.08x |
| EV / EBITDA | - | -9.71x | -12x | 52.8x | 24.8x | 11.7x | 8.58x | 5.72x |
| EV / EBIT | - | -9.13x | -11.2x | 76.5x | 36.9x | 14.3x | 10.2x | 6.52x |
| EV / FCF | - | -9.04x | -11.5x | -18.3x | -18.7x | -46.5x | -83.6x | 45.6x |
| FCF Yield | - | -11.1% | -8.72% | -5.45% | -5.36% | -2.15% | -1.2% | 2.2% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -12.29 | -2.6 | -2.43 | -0.87 | 0.54 | 0.3684 | 0.4318 | 0.6362 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 36.77 | 83.03 | 93.38 | 492 | 588.9 | 660.8 | 799.8 | 983.7 |
| EBITDA 1 | - | -326 | -330.6 | 100.9 | 116.1 | 182.2 | 253.3 | 358.6 |
| EBIT 1 | - | -346.4 | -354.9 | 69.64 | 78.21 | 149.6 | 212.6 | 314.5 |
| Net income 1 | - | -513.6 | -551.7 | -231.9 | 157.9 | 164.6 | 134.4 | 185.7 |
| Net Debt 1 | - | 678.2 | 911 | 1,340 | 1,277 | 1,048 | 1,081 | 957.9 |
| Reference price 2 | 9.880 | 10.000 | 11.480 | 13.230 | 5.130 | 3.060 | 3.060 | 3.060 |
| Nbr of stocks (in thousands) | 31,250 | 248,650 | 265,530 | 301,640 | 313,019 | 356,912 | - | - |
| Announcement Date | 10/05/22 | 01/03/23 | 20/03/24 | 26/03/25 | 18/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 8.31x | 3.24x | 11.74x | -.--% | 1.09B | |
| 32.25x | 5.76x | 17.3x | 1.02% | 46.86B | |
| -23.62x | 354.58x | -21.66x | -.--% | 40.23B | |
| 48.91x | 4.94x | 31.87x | -.--% | 36.23B | |
| 25.32x | 2.8x | 12.1x | -.--% | 34.72B | |
| 27.42x | 8.04x | 20.17x | 0.41% | 27.89B | |
| 34.31x | 5.61x | 25.58x | -.--% | 16.79B | |
| 22.12x | 1.95x | 8.48x | 1.19% | 13.12B | |
| 23.43x | 1.87x | 11.34x | -.--% | 12.7B | |
| Average | 22.05x | 43.20x | 12.99x | 0.29% | 25.51B | |
| Weighted average by Cap. | 22.43x | 66.11x | 12.08x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ALVO Stock
- Valuation Alvotech
Select your edition
All financial news and data tailored to specific country editions
